Human Vaccines against Infectious Diseases

Infectious diseases are responsible for approximately 25% of global mortality, especially in children aged younger than 5 years. Much of the burden of infectious diseases could be alleviated if appropriate mechanisms could be put in place to ensure access for all children to basic vaccines, regardless of geographical location or economic status. In addition, new safe and effective vaccines should be developed for a variety of infections against which no effective preventive intervention measure is either available or practical. The public, private, and philanthropic sectors need to join forces to ensure that these new or improved vaccines are fully developed and become accessible to the populations in need as quickly as possible.

  • Anthrax vaccines
  • Measles vaccines
  • Rubella vaccines
  • Cholera vaccines
  • Meningococcal vaccines
  • Influenza vaccines
  • Diphtheria vaccines
  • Mumps vaccines
  • Tetanus vaccines
  • Hepatitis vaccines
  • Pertussis vaccines
  • Tuberculosis vaccines
  • Pneumococcal vaccines
  • Typhoid fever vaccines
  • Poliomyelitis vaccines
  • Tick-borne encephalitis vaccines
  • Haemophilus influenza type b vaccines
  • Rabies vaccines
  • Varicella and herpes zoster (shingles) vaccines
  • Human papilloma-virus vaccines
  • Rotavirus gastroenteritis vaccines
  • Yellow fever vaccines
  • Japanese encephalitis vaccines
  • Dengue fever vaccines
  • Vaccines for emerging & re-emerging diseases

Related Conference of Human Vaccines against Infectious Diseases

July 27-28, 2018

31st Annual Congress on Vaccines & Clinical Trials

Vancouver, Canada
October 22-23, 2018

30th World Congress on Vaccines and Immunization

Osaka, Japan

Human Vaccines against Infectious Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in